Tocilizumab in Refractory Autoimmune Encephalitis: A Series of Pediatric Cases

IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY
Rachel L. Randell MD , Ashley V. Adams BA , Heather Van Mater MD
{"title":"Tocilizumab in Refractory Autoimmune Encephalitis: A Series of Pediatric Cases","authors":"Rachel L. Randell MD ,&nbsp;Ashley V. Adams BA ,&nbsp;Heather Van Mater MD","doi":"10.1016/j.pediatrneurol.2018.07.016","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Autoimmune encephalitis<span> can result in significant neurological and psychiatric morbidity and mortality in patients<span> of all ages and often does not respond to standard therapies. Recent reports suggest efficacy of tocilizumab<span>, a monoclonal antibody against interleukin 6, in refractory autoimmune encephalitis.</span></span></span></p></div><div><h3>Results</h3><p>We describe three children with refractory autoimmune encephalitis who experienced a robust, immediate clinical response following treatment with tocilizumab.</p></div><div><h3>Conclusion</h3><p>These findings support the efficacy and short-term safety of tocilizumab as a third-line treatment for refractory autoimmune encephalitis in children.</p></div>","PeriodicalId":19956,"journal":{"name":"Pediatric neurology","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2018-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.pediatrneurol.2018.07.016","citationCount":"37","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric neurology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0887899418303667","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 37

Abstract

Background

Autoimmune encephalitis can result in significant neurological and psychiatric morbidity and mortality in patients of all ages and often does not respond to standard therapies. Recent reports suggest efficacy of tocilizumab, a monoclonal antibody against interleukin 6, in refractory autoimmune encephalitis.

Results

We describe three children with refractory autoimmune encephalitis who experienced a robust, immediate clinical response following treatment with tocilizumab.

Conclusion

These findings support the efficacy and short-term safety of tocilizumab as a third-line treatment for refractory autoimmune encephalitis in children.

托珠单抗治疗难治性自身免疫性脑炎:一系列儿科病例
背景:自身免疫性脑炎可在所有年龄的患者中导致显著的神经和精神发病率和死亡率,并且通常对标准治疗无效。最近的报道表明tocilizumab,一种针对白细胞介素6的单克隆抗体,对难治性自身免疫性脑炎有效。结果:我们描述了3例难治性自身免疫性脑炎患儿,他们在接受托珠单抗治疗后立即出现了强劲的临床反应。结论:这些研究结果支持tocilizumab作为儿童难治性自身免疫性脑炎三线治疗的有效性和短期安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pediatric neurology
Pediatric neurology 医学-临床神经学
CiteScore
4.80
自引率
2.60%
发文量
176
审稿时长
78 days
期刊介绍: Pediatric Neurology publishes timely peer-reviewed clinical and research articles covering all aspects of the developing nervous system. Pediatric Neurology features up-to-the-minute publication of the latest advances in the diagnosis, management, and treatment of pediatric neurologic disorders. The journal''s editor, E. Steve Roach, in conjunction with the team of Associate Editors, heads an internationally recognized editorial board, ensuring the most authoritative and extensive coverage of the field. Among the topics covered are: epilepsy, mitochondrial diseases, congenital malformations, chromosomopathies, peripheral neuropathies, perinatal and childhood stroke, cerebral palsy, as well as other diseases affecting the developing nervous system.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信